Pimún develops a non-invasive medical device that gently stimulates the back of premature infants to prevent apnea of prematurity (AOP) and improve their breathing patterns during sleep. This technology reduces the frequency of apnea events, shortens hospital stays, and enhances operational efficiency in neonatal intensive care units.
Funding
Funding not disclosed
Founders
Product
Problem
Apnea of prematurity (AOP), characterized by pauses in breathing, is a common and potentially dangerous condition in premature infants. Current interventions often rely on manual tactile stimulation by nurses, which is labor-intensive and can be inconsistent. This can lead to prolonged hospital stays and increased costs for neonatal intensive care units (NICUs).
Solution
Pimún has developed a non-invasive medical device that automates tactile stimulation for premature infants to prevent AOP. The device gently stimulates the baby's back, guiding their breathing patterns during sleep. By providing consistent and personalized stimulation, the technology reduces the frequency of apnea and intermittent hypoxia events. This leads to improved breathing and oxygenation, reduced reliance on manual intervention by nurses, and the potential for shorter hospital stays.
Target Audience
The primary target audience is neonatal intensive care units (NICUs) and hospitals caring for premature infants at risk of apnea of prematurity.
Features
- Non-invasive tactile stimulation to prevent apnea of prematurity (AOP)
- Automated and personalized stimulation based on infant's needs
- Reduces AOP and intermittent hypoxia events
- Improves breathing and oxygenation
- Automates tactile stimulation, relieving nurses' workload